Polymun Scientific Immunbiologische Forschung GmbH

Founded

1992

Staff

79

Organization type

RDM biotech/pharma

Region

Lower Austria

The core activities of Polymun are contract development and GMP manufacturing of biopharmaceuticals as well as liposomal formulations of APIs and vaccine antigens – for clinical studies and the market. Revenues are invested in own R&D projects and the further development of technology platforms. Polymun operates in accordance with current GMP guidelines and holds an Austrian production license thus meeting all EU for drug manufacturing. In addition, Polymun’s facility is accepted by the US FDA.

Production:Mammalian cell culture Microbial cell culture Liposome technology

Services:Contract development and manufacturing of biopharmaceuticals Contract development and manufacturing of liposomal formulations

Sales/Distribution:Manufacturing and distribution of research reagents, mainly for HIV research